To date, data has been published in peer-reviewed publications on LymPro with 160 patients, demonstrating 92% co-positivity and 91% co-negativity with an overall 95% accuracy rating for LymPro
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links